Scenario 2: Inadvertent Exposure 32-year-old woman with T2DM on semaglutide, presents at 8 weeks gestation G2P0L0A1.First trimester pregnancy loss due to high blood glucose levels Management- Stop Sema Reassurance based on current evidence Detailed risk counseling using available data HbA1C specially Enhanced monitoring with detailed ultrasound Multidisciplinary approach Documentation and registry participation if available What Guidelines Say
For many people, the better option comes down to insurance coverage and cost rather than effectiveness differences
The third hormone, glucagon, speeds up metabolism and helps the body break down fat cells for energy
No Phase III anti-inflammatory endpoint
This course is intended for: RDNs, CDCESs and NDTRs GLP-1 Therapy for Patients with Obesity: Identifying Solutions to Optimize Nutrition awards 3.75 CPEUs in accordance with the Commission on Dietetic Registration CPEU Approval
Its no longer enough, it seems, to log a bewildering number of steps and reps each day